Title : Lorcaserin treatment for extended-release naltrexone induction and retention for opioid use disorder individuals: A pilot, placebo-controlled randomized trial.

Pub. Date : 2021 Feb 1

PMID : 33418204






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The purpose of this trial was to determine if lorcaserin, a 5HT2c agonist, improves outpatient XR-NTX induction rates. lorcaserin 5-hydroxytryptamine receptor 2C Homo sapiens